These results demonstrate that both GABA A -mediated inactivation and tonic up-regulation of IN cells can interrupt the expression of conditioned eyeblinks and that this behavioral effect is accompanied by the suppression of the neuronal activity correlates of the conditioned stimulus and response.
I N T R O D U C T I O N
Classical conditioning of eyeblink responses in rabbits is one of the most successful paradigms used to investigate neural substrates of associative learning in mammals. An intriguing feature of this model is that the acquisition and expression of learned responses [conditioned eyeblinks (conditioned responses, CRs)] critically depend on intermediate cerebellumrelated circuits. The cerebellar interposed nuclei (IN) are key parts of this network. It is known that lesions or inactivation of the IN prevent both the acquisition of new conditioned eyeblinks (Krupa and Thompson 1997; Lincoln et al. 1982; Ramnani and Yeo 1996; Yeo et al. 1985) as well as the expression of previously learned responses (Bracha et al. 1994; Chapman et al. 1990; McCormick et al. 1982; Welsh and Harvey 1991) . The precise role of the IN in conditioned response acquisition and retention is not clear. A number of recent studies examining IN involvement in eyeblink conditioning utilized microinjections of drugs to locally affect the functionality of the IN. Interpretations of these neuropharmacological studies, however, are limited, because the effects of the drugs on the activity of IN cells were not directly measured.
It is known that the IN receive two main inputs. The first is a relatively weak glutamatergic input from cerebellar afferents-collaterals of mossy and climbing fibers. Although this input plays a prominent role in some of the current hypotheses of cerebellar involvement in eyeblink conditioning (Medina et al. 2000; Steinmetz 2000; Thompson 1986 ; Thompson and Kim 1996) , its precise function is unknown since it has not been thoroughly investigated. The second is the strong GABAergic input from the cerebellar cortex (Ito 1984) . It is known that applying ␥-aminobutyric acid-A (GABA A ) agonists in the IN blocks the acquisition and expression of eyeblink CRs (Bracha et al. 1994; Krupa et al. 1993 ). This dramatic effect is most likely associated with the substantial inactivation of IN cells. On the other hand, injections of GABA A antagonists have varying reported effects including small effects on CR expression (Bracha et al. 2001) , effects on CR timing and amplitude (Bao et al. 2002; Garcia and Mauk 1998) , or abolishing CR expression (Bao et al. 2002; Mamounas et al. 1987) . Based on the available behavioral data, several studies have made specific predictions about the expected effects of injected drugs on IN activity. For example, Garcia and Mauk (1998) , who reported that relatively small doses of picrotoxin applied to the IN decrease the latency of CRs, predicted that the main effect of blocking the chloride channels of IN neurons would be shortening the latency of their response to the CS. Based on this assumption, it was proposed that the major role of the cerebellar cortex is to regulate the timing of the CR (Garcia and Mauk 1998) . In our study which examined the effects of picrotoxin injections in the IN on tonic eyelid position, we predicted that manipulations of GABA A neurotransmission affect not only the modulation of IN neural activity but also its tonic level. This speculation was used in supporting the hybrid hypothesis of cerebellar function which proposes that both tonic and phasic components of IN activity are relevant to eyeblink circuits (Bracha et al. 2001) .
To test the predictions of the timing and hybrid hypotheses, we designed an experiment in which we directly measured the effects of locally applied GABA antagonist picrotoxin on the expression of eyeblink CRs and IN neuronal activity simultaneously. For that purpose, we developed a micromanipulator/ guide tube system that permits stable recording of extracellular single-unit activity close to the site of drug injection. Rabbits were implanted with guide tubes and electrodes and were classically conditioned. Trained animals were injected with muscimol to verify the functional relationship between the injection site and the expression of conditioned eyeblinks. Rabbits in which the inactivation of the IN abolished CR expression were then injected with picrotoxin, and its effects on the animal's behavior and IN activity were measured simultaneously.
M E T H O D S
The experiments were performed in six male New Zealand white rabbits (2.5-3.0 kg, 3-4 mo old at the start of experiments) which were provided with food and water ad libitum. All experiments were performed in accordance with the National Institutes of Health "Principles of Laboratory Animal Care" (National Institutes of Health publication No. 86-23, revised 1985) , the American Physiological Society's "Guiding Principles in the Care and Use of Animals," and the protocol approved by Iowa State University's Committee on Animal Care.
Surgery
Animals were anesthetized with a mixture of ketamine (50 mg/kg), xylazine (6 mg/kg), and acepromazine (1.5 mg/kg). Skull anchor screws, together with an assembly of three guide tubes that was aimed 0.5 mm dorsal to the left cerebellar interposed nuclei, were implanted using sterile surgical procedures. The guide tube assembly consisted of three parallel 26-gauge stainless steel tubes arranged in an equilateral triangle with a distance of 0.8 mm between them. Two of the guide tubes contained a bundle of five microwires (a total of 10 microwires, stainless steel, 18 m diameter, Formvar insulation). The microwire bundles were attached to a permanently implanted micromanipulator that permitted vertical adjustments of their position. The microwires were connected to a small 15-pin connector that was embedded in dental acrylic. The third guide tube was used for microinjections of drugs. The patency of the injection needle cannula was protected by a 33-gauge stainless steel stylet. During surgery, lambda was positioned 1.5 mm below bregma and the stereotaxic coordinates were as follows: AP ϭ 0.2-1.2 mm rostral to lambda, ML ϭ 5.2 mm from midline, and DV ϭ 14.7 mm ventral to lambda. A small Delrin block designed to accommodate the air tube required for air-puff stimulation and the device used to measure the movement of the upper eyelid during experiments in addition to the rest of the implanted hardware was attached to the skull using anchoring screws and dental cement. All animals were treated with antibiotics for 1 week following surgery.
Training procedures
After surgery, rabbits were adapted to the restraining box and to the experimental environment for 3 days, 30 min per day. Following adaptation, rabbits were conditioned in the standard delay paradigm using a 100-ms air puff (210 kPa at the source) applied to the left eye as the unconditioned stimulus (US) and a 450-ms, 80-dB SPL, 1-kHz tone as the CS superimposed on 65 dB SPL of white noise. The interstimulus interval was 350 ms, and the intertrial interval varied pseudorandomly between 17 and 23 s. All animals were trained until they produced CRs in more than 90% of the trials for three consecutive days. The movement of the eyelids was not restricted. Although conditioned responses in this task could not affect the incidence of delivery of the US, they could modify the perception of the US by the animal. Strictly speaking, this paradigm does not conform to all of the common criteria of a classical conditioning paradigm (Gormezano et al. 1983) . With this caveat in mind, the described task will still be referred to as a classical conditioning paradigm.
Injection and recording experiments
All trained rabbits were tested in experiments in which the cerebellar interposed nuclei was microinjected with solutions of either muscimol (ICN Biochemicals, 3.5 nmol/l) or picrotoxin (PTX) (Sigma, 0.4 or 2.5 nmol/l), and the effects of these drugs on eyeblinks as well as on the activity of IN neurons were monitored. Both drugs were dissolved in artificial cerebral spinal fluid (ACSF). All injections were delivered through a 33-gauge stainless steel needle inserted in the implanted guiding tube. The injection needle was connected to a 10-l Hamilton syringe using transparent Tygon tubing. The injected volume was measured by observing the movement of a small air bubble relative to gradation marks on the tubing connecting the needle to the syringe. Most of the drug injections were performed with the injection needle tip flush with the end of the guide tube. Only one drug was injected on any given experimental day. The main objective of muscimol injections was to functionally test whether the guide tube for the injection needle was implanted in the IN region related to CR control. Based on previous studies (e.g., Bracha et al. 1994) , it was expected that muscimol will abolish CRs in successfully implanted animals. During muscimol experiments, a single 0.5 l injection was applied after 40 baseline trials. In each picrotoxin experiment, there were two 0.5 l injections applied at a rate of 0.05 l/min. These injections divided each experiment into three blocks of trials-40 trials before any injections (baseline period), 80 trials following the first injection, and an additional 80 trials following the second injection. Equal volumes of vehicle (ACSF) were injected following the same procedure in control experiments.
Recording single-unit activity in the vicinity of a pressure-injected drug presents a technological problem since an experiment of this type requires long-term (approximately 2 h) maintenance of the same set of recorded units. The stability of the recorded units depends on the extent that the electrodes drift relative to the recorded neurons. To maximize signal stability, adjustments of the position of the electrodes were made 1 day prior to injection experiments. All injection experiments were performed only on days when the signal was acceptable and did not require re-positioning of electrodes. To further increase recording stability, only small volumes of the drugs (0.5 l) were injected at a very slow rate to minimize tissue displacement caused by the injected volume of fluid. Despite these precautions, occasionally, the recorded set of cells could not be maintained throughout the experiment, as evidenced by a sudden disappearance of the signal or by a change in the shape of the recorded action potentials. In this study, we present data only from the experiments which yielded stable recording. The first injections in each animal were functional muscimol tests. In the muscimol injection experiments, no efforts were made to find and record cells that would respond in the CS-US interval. Picrotoxin injection experiments were initiated in animals in which 0.5 l of muscimol completely blocked CR expression. Prior to picrotoxin experiments, the electrodes were advanced to positions yielding cells that responded in the CS-US interval. It should be noted that this sampling strategy in PTX experiments most likely resulted in over-representation of the CS-and CR-related neurons in the IN. Once a set of neurons was recorded successfully during picrotoxin and/or control experiments, the electrodes were re-positioned to search for a new set of IN cells. Consequently, several sets of cells were recorded in the vicinity of each injection site.
Data recording and analysis
The eyeblink was recorded by monitoring the upper eyelid position with an electro-magnetic lever system (Bracha et al. 2001) . Eyeblink responses were considered CRs when they exceeded the mean of the signal before CS onset by more than seven SDs of the noise (approximately 0.25 mm). Spontaneous responses were defined as trials in which the difference between the maximum and minimum values in the baseline period before the onset of the CS exceeded 1 mm.
Spontaneous responses were stored but were discarded from further data analysis. For each experiment, CR incidence, CR onset, and CR amplitude were calculated for the periods before and after the injection.
The multiple single-unit signals from the microwires were fed through a custom miniature 14-channel FET-based preamplifier to a multi-channel differential amplifier system (Grass-Telefactor model 12 Neurodata System). The amplified and band-pass-filtered (300 Hz-3 kHz) signal was digitized (25 kHz/channel) using a custom data acquisition system, displayed, and stored in 1400-ms epochs corresponding to individual trials. Unit discrimination was performed offline using threshold detection followed by a cluster analysis of scatter plots of time and amplitude distances between the peak and valley of individual action potential wave shapes. Up to three units could be discriminated on each channel. The discriminated data were processed using custom software in addition to a commercial data analysis pack (NeuroExplorer, Nex Technologies). Raster and peri-event histograms were constructed for each unit and experiment. Separate histograms were constructed for baseline trials, trials after the first injection, and trials after the second injection. In each histogram, the baseline firing rate (250 ms before CS onset) and the time occurrence of significant excitatory and inhibitory changes were computed. Cell responses were considered significant if the modulation of the firing rate in the post-CS period exceeded the mean baseline Ϯ tolerance limit for two consecutive 10-ms bins. The factor for the tolerance limit was computed based on the statistical assumption that 99% of observations should not exceed the tolerance limit with a probability of 0.95. Individual normalized cell histograms (spike frequency in Hz) were pooled together for each cell type, drug, and period of time to construct average population histograms. Baseline means of individual cell histograms were pooled together for each type of drug, concentration, and part of the experiment and statistically analyzed. Also, all histograms were binarized, with the logical one representing bins significantly exceeding the baseline rate. The binarized histograms were summarized to construct modulation frequency histograms depicting the relative number of cells showing significant excitatory and inhibitory modulation at each given time during the trial.
The statistical analysis of individual parameters of eyeblink responses, of the baseline firing of IN neurons, and of population histograms, was conducted using two factorial ANOVA with the following factors: drug (2 levels, PTX and ACSF) and time/dose (3 levels, before injection, after the first injection, and after the second injection). A separate analysis was performed on the results of the muscimol injection experiments which included only one injection. ANOVA was followed by Newman-Keuls post-hoc analysis. All of the significant data in RESULTS are based on the post-hoc analysis unless specified otherwise. The provided numerical results are group means Ϯ SE. Also, all significant effects of PTX were significant when compared to both the preinjection level and the corresponding time period in the control experiment, unless specified otherwise. All statistical analyses were performed using Statsoft Statistica (a commercial analytical software package). The level for the rejection of the null hypotheses was set to P Ͻ 0.05 in all tests.
Histology
After completion of the experiments, animals were deeply anesthetized, and the injection sites were marked by injecting 1 l of tissue marking dye. The location of electrodes was marked by passing 10 A anodal DC current through each wire for 20 s. The animals were transcardially perfused with 1 L of phosphate-buffered saline followed by 1 L of fixative (10% buffered formalin) and 1 L 10% potassium ferrocyanide in 10% formalin. The perfused brains were removed from the skull and, following a postfixation in 30% sucrose formalin, sectioned coronally at 50 m on a freezing microtome.
Sections were mounted onto gelatin-coated slides, reacted with ferrocyanide hydrochloride to visualize electrode-recording sites, and then stained with neutral red. The location of the injection sites as well as electrodes were determined and transferred to a standardized set of 0.5-mm separated coronal sections of the rabbit cerebellum.
R E S U L T S
The histological reconstruction of injection and recording sites revealed that all injection sites were located in the anterior interposed nucleus and most of recording sites were located either in the anterior interposed nucleus or at the anterior interposed/dentate nucleus boundary (Fig. 1) . The theoretical expected distance between the recording and injection sites was 0.8 mm. Based on the variable trajectory of microwire travel through the brain tissue, the real distance between the recording sites and the drug injection site was estimated to be in the range of 0.3-1.2 mm.
Effects of muscimol and picrotoxin on eyeblink conditioned responses
All of the effects of the picrotoxin injections reported in this paper were observed following PTX infusion at sites at which a previous infusion of 0.5 l of muscimol (1.75 nmol ϭ 200 ng) abolished the expression of classically conditioned eyeblinks ( Fig. 2A) . In general, the effects of PTX on CR expression were dose-dependent. In preliminary experiments, we tested the effects of injecting two 0.5 l injections of PTX, 0.2 nmol each. In these experiments, both the behavioral and the electrophysiological effects of this PTX dose were sporadic FIG. 1. Reconstruction of injection (ϫ) and recording (black dots) sites. The identified sites were transferred to a set of standardized coronal sections of the rabbit cerebellum. A-C: 3 adjacent (0.5 mm apart) sections through the cerebellum, arranged in rostral-caudal order. All injection sites and most of recording sites were located directly in or in close vicinity of the anterior interposed nucleus and of the anterior interposed/dentate nuclear border. InA, anterior interposed nucleus; DN, dentate nucleus; LV, lateral vestibular nucleus; SV, superior vestibular nucleus; InP, posterior interposed nucleus; FN, fastigial nucleus; scp, superior cerebellar peduncle; icp, inferior cerebellar peduncle. and marginal. More pronounced behavioral and electrophysiological effects were observed when 1.25 nmol (750 ng) of PTX in 0.5 l ACSF was injected. The first microinjection (1.25 nmol of PTX) decreased CR latency, had the tendency to decrease the relative amplitude of CRs, slightly decreased CR incidence, and also slightly increased tonic eyelid closure. The second injection of PTX (an additional 1.25 nmol) increased CR latency to the preinjection level, increased tonic eyelid closure, and eventually abolished CRs (Fig. 3) .
At the group level, the latency of CRs before the injection was 227.5 Ϯ 8.3 ms (n ϭ 15, group means Ϯ SE). After the first injection, the latency significantly decreased to 200.1 Ϯ 11 ms. Interestingly, the second injection of PTX that eventually abolished CRs initially prolonged CR latency to the preinjection level (Fig. 4C ). Injections of ACSF had no significant effects on CR latency (Fig. 4C) . Injections of PTX decreased CR incidence at the group level in a dose-dependent manner (Fig. 4A) . CR incidence significantly decreased from 90.7 Ϯ 1.24% preinjection level to 73.6 Ϯ 2.05% following the first injection and to 30.8 Ϯ 6.3% following the second injection (Fig. 4A) . Although tonic eyelid closure following the first PTX injection was not significant at the group level, it was highly significant following the second PTX injection (Fig.  4B) . The described group effects were not an all or nothing phenomena. On the contrary, the effects on behavior usually developed over the time. For instance, in many cases CRs were abolished following the second PTX injection. This effect, however, developed over a short time period following the injection of the drug (Fig. 3, see also Fig. 4A ), most likely reflecting the time course of drug diffusion.
Other behavioral effects of picrotoxin injections
The present experiments were performed in conditions which minimized head and eyelid restraint. This permitted the unobstructed observation of several behavioral side effects of the picrotoxin injections. Besides effects on the eyeblink reflex, picrotoxin infusions in the IN produced several types of behavioral anomalies in most of the rabbits. The following picrotoxin side effects were observed: asymmetry of the facial musculature that was mostly expressed as tonic flexion of the upper lip on the side ipsilateral to the air puff (47% of cases). This effect was often accompanied by an apparent protrusion of the contralateral eyeball (20% of cases). Picrotoxin infusions were followed by head rotation along the rostro-caudal axis, to the right side (away from the injected side) (100% of cases). These frequencies of behavioral PTX side effects were observed following the second PTX injection. Interestingly, most of the picrotoxin-induced behavioral changes were contingent on the restraint of the animal. The above behaviors, with the exception of the contraction of the ipsilateral lip, either diminished or could not be detected immediately on the removal of the rabbit from the restraining box. 
Effects of muscimol and picrotoxin injections on the activity of cells in the IN
Eighty cells were recorded during functional muscimol tests. Activating GABA A receptors using muscimol abolished behavioral CRs and dramatically diminished the firing rate of IN cells (Fig. 2, B and C) . The baseline firing rate of the recorded population of neurons was 20.8 Ϯ 1.9 Hz (n ϭ 80) before the injections and significantly decreased to 6.2 Ϯ 1.1 Hz following the application of muscimol. This dramatic decrease of the firing rate was accompanied by almost the complete suppression of neuronal responses in the CS-US interval.
During PTX experiments, 162 cells were recorded from the deep cerebellar nuclei. The locations of the recording sites are shown in Fig. 1 . Based on the firing properties of these cells, they were subdivided into four groups. Among the responding cells, the most common were medium-frequency cells (MFC) with excitatory responses (n ϭ 55, Fig. 5A ). The MFC cells had baseline firing frequencies of approximately 20 Hz, and they exhibited large excitatory (frequently Ͼ100 Hz) responses in the CS-US interval. This excitatory response was often followed by an inhibition that started approximately 50 ms following US onset. In the second largest responding cell group were low frequency cells (LFC) that exhibited mostly excitatory responses (n ϭ 32, Fig. 5D ). LFC cells had low baseline firing rates (2-10 Hz), and their peak excitatory responses reached Յ60 Hz. In the third group of significantly modulated neurons were high-frequency cells (HFC) with inhibitory responses (n ϭ 14, Fig. 5G ). HFC cells typically had a baseline activity of 25-55 Hz and exhibited a relatively small, short-latency excitatory response to the CS and a large inhibitory response to the US. The remainder of recorded cells did not exhibit significant firing modulation before PTX injections (n ϭ 61, non-responding cells, NRC).
Injections of PTX affected the baseline firing rate as well as the responses to stimuli in all types of cells in a dose-dependent manner. In general, the spontaneous firing rate of all cells increased after injections, and both excitatory and inhibitory responses were diminished or abolished. A typical example of this effect is illustrated in Fig. 5 , A-C, which depicts averaged peri-stimulus histograms of MFC during a PTX experiment. As indicated above, MFC spontaneous activity averaged 20 Hz, and these cells responded with a large increase in activity to the CS that was frequently followed by an inhibition related to the US (Fig. 5A) . Following the first injection of PTX, the baseline firing rate of MFC cells dramatically increased and cell modulation was reduced (Fig. 5B) . The second injection of PTX further increased baseline discharge frequency and diminished responses to the CS and US (Fig. 5C) . In many cells, the responses to the CS were completely abolished. Qualitatively similar changes of neuronal activity were observed in the other modulated cell types (Fig. 5, D-I ). These observations contrasted with control experiments, in which injections of ACSF had little effect on spontaneous IN neuronal activity (Fig. 5,   FIG. 4 . Summary of behavioral effects of picrotoxin (PTX, n ϭ 15) and vehicle (artificial cerebrospinal fluid, ACSF, n ϭ 12) microinjections. A: effects of picrotoxin on mean CR incidence (ϮSE). I1, the first injection (0.5 l); I2, the second injection (0.5 l, bringing the total volume to 1 l). Note that the first injection affected CR incidence only slightly. CRs were gradually abolished following the second injection. B: relative effects of PTX and ACSF injections on the tonic position of the upper eyelid (group means Ϯ SE). Positive values of eyelid displacement indicate eyelid closure relative to the mean eyelid position before the first injection. Note that picrotoxin produced tonic eyelid closure in a dose-dependent manner. C: effects of PTX and vehicle on mean CR latency (ϮSE). Note a slight decrease of CR latency following the first injection of PTX. The second injection brought CR latency back to the preinjection level. The calculation of means included only those trials during which a CR was detected. The asterisks indicate a significant change when compared with preinjection levels.
M-O).
Interestingly, even in the ACSF experiments, the depth of firing modulation slightly decreased toward the end of the experiment. A gradual decrease of cellular responses was frequently observed in experiments that did not involve any injections. It could be that this decrease of responses was related to the fatigue of the neuronal substrates involved in their generation. The effects of PTX on the incidence of neuronal responses at the population level are illustrated in Fig.  6 . The first injection of PTX significantly reduced the number of cells responding in the CS-US interval by more then onehalf when compared with the preinjection level. The second PTX injection abolished responses in the CS-US interval in most of the cells. A similar decrease in the number of responding cells following PTX injections was observed during the analysis of the frequency of significant inhibitory responses. Most of these responses were observed following the delivery of the US (Fig. 6A) . The majority of the inhibitory responses was abolished following the second PTX injection (Fig. 6C) . Interestingly, PTX injections frequently "unmasked" excitatory responses to the US that were not apparent before the injections (Fig. 5, C, F, and L) . Unexpectedly, this PTXinduced responding was actually most apparent in cells that did not respond to any stimuli before the injection. Twenty-eight of the 61 originally NRC exhibited significant responses to the US following the PTX injections. This subpopulation of NRC is shown in Fig. 5 , J-L.
ANOVA performed on the baseline firing rate of all recorded cells yielded significant effects of drug and of the injection number. Post-hoc analysis revealed that the first PTX injection elevated the mean firing rate of the recorded population of cells from 17.4 Ϯ 1.1 to 39.5 Ϯ 2.2 Hz (n ϭ 101). The second PTX injection further elevated the mean firing rate to 55.3 Ϯ 2.8 Hz. No significant changes of spontaneous firing rate were observed in control experiments. The analysis of population histograms of the frequency of excitatory responses (Fig. 6 ) revealed a significant decrease of excitatory response incidence following both the first and the second PTX injection. The frequency of inhibitory responses was not affected by the first PTX injection, but it significantly decreased following the second PTX injection. Changes in the frequency of both This is the first study that documents the effect of manipulating GABA A receptor-mediated neurotransmission in the IN on both the expression of classically conditioned eyeblinks and the single-unit activity of IN neurons in the area of drug injection simultaneously. We found that injections of GABA A receptor agonist muscimol and of GABA A antagonist picrotoxin (a chloride channel blocker) blocked CR expression and dramatically affected tonic activity as well as the modulation of IN cells.
Behavioral effects of muscimol and picrotoxin microinjections
As expected, inactivating the IN with muscimol abolished the expression of conditioned eyeblinks. This result confirms a number of previous reports (e.g., Bracha et al. 1994) . Blocking chloride channels with picrotoxin had the three following major behavioral effects: 1) effects on eyeblink CR expression; 2) effects on the tonic position of the external eyelid; and 3) motor side effects on facial and head/neck musculature. The first two effects partly confirm previously reported results. The first picrotoxin injection decreased the latency of conditioned responses at the group level. Overall, the effects of PTX injections on CR latency resemble those previously reported (Bao et al. 2002; Garcia and Mauk 1998; Medina et al. 2001) . Although muscimol injections in all cases included in this report abolished the expression of CRs, the effects of the first dose of picrotoxin injected at the same sites were surprisingly variable. In two rabbits, the decrease of CR latency was not observed.
The source of this variability, that has not been reported previously, is not clear. It should be pointed out that the present study differs from previous experiments in several aspects. For example, we used a shorter inter-stimulus interval (350 vs. 450 ms). It cannot be excluded that the timing of CRs acquired with the shorter inter-stimulus interval is less sensitive to pharmacological manipulations of the IN. In the present study, the effects on CR latency were observed following injections of 1.25 nmol PTX. Although this amount of the drug is higher than in the study of Garcia and Mauk (1998) (who used 0.2-0.4 nmol PTX), it is lower than another study that reported more dramatic effects of PTX on CR latency (Medina et al. 2001; 2 nmol) . Since the PTX dose used in the present study is in the range of previously reported effective amounts of the drug, it seems unlikely that the drug dose would be solely responsible for the relatively modest effects of PTX on CR latency in the present experiments. It seems more likely that the magnitude of the CR latency-decreasing effect of picrotoxin is related to a specific subpopulation of IN cells or to a specific PTX concentration at a relevant and so-far not precisely mapped part of the IN. The second injection of PTX initially increased CR latency to the preinjection level and eventually abolished CRs. This finding confirms previous reports of effects of high doses of PTX on CR expression (Bao et al. 2002; Mamounas et al. 1987) . Besides the effects on conditioned eyeblinks, both PTX injections increased tonic eyelid closure. This finding supports our previous report (Bracha et al. 2001) and demonstrates that the output of the interposed nuclei controls both the phasic and the tonic components of eyelid movement. The several other side effects of PTX injections indicate that despite relatively small injected volumes, the drug spread to adjacent parts of the IN that are related to facial and head/neck effector systems. FIG. 6 . Population histograms of the relative incidence of significant excitatory (black line) and inhibitory (gray line) responses in the population of 101 cells recorded in the PTX experiments (A, before injection; B, after first PTX injection; C: after second PTX injection) and 48 cells recorded in control experiments (D, before injection; E, after first ACSF injection; F, after the second ACSF injection). Most of the recorded neuronal responses were excitatory. The first PTX injection clearly reduced the incidence and the second PTX injection practically abolished both the excitatory responses to the CS and the inhibitory responses to the US. Interestingly, the number of cells responding to the US with excitation increased (C). This effect of PTX contrasts with a mild (and insignificant) decline of response incidence in control experiments (D-F).
results also suggest that the behavioral expression of CRs depends on an optimal level of spontaneous IN activity and on the appropriate amplitude of IN modulation. The relative contribution of the tonic and phasic components of IN firing in CR expression remains to be resolved.
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